Laboratory Services


Metropolis denies it is open to bidders

Metropolis Healthcare, the big Indian diagnostic and pathology group, is determined to forestall potential predators despite talk of a $1bn joint bid from hospital chain Apollo and conglomerate Adani Group.

Atrys buys Bienzobas for €76.3m

Despite its recent share price falls, highly acquisitive Spanish laboratory diagnostic group Atrys Health is to buy Bienzobas for €76.3m, a Spanish company which provides oncology services to insurance companies and hospital groups.

Largest lab group in GCC likely to list

Al Borg Diagnostics with 64 labs across 8 countries in GCC and Africa and a dominant position in Saudi Arabia, its home market, looks set to finally list in 2022. We speculate (wildly!) on valuation.

Swiss imaging and lab groups sigh with relief

A new outpatient tariff which would have taken 6-10% points off imaging prices has been kicked down the road for the third time by the byzantine Swiss healthcare system. It would have severely clipped the very high margins enjoyed by many whilst upping prices for primary care.

RNA Covid vaccines could have adverse non-specific effects

A new meta-analysis study examining the results from Covid vaccine trials suggests a worrying possibility: that mRNA Covid vaccines, despite protecting against Covid, could reduce the immune system's overall ability to fight infections. On the other hand, the study’s findings also suggest the adenovirus Covid vaccines could have the opposite effect. To many this will sound far-fetched, or even the stuff of conspiracy theory, but University of Southern Denmark’s Professor Christine Stabell-Benn, who led the research, explains to HBI that epidemiologists have known for decades that vaccines can have such ‘nonspecific’ effects and emphasises that regulatory frameworks are in dire need of being updated to reflect this.

Interview: Joe Stringer, partner, Octopus Ventures

Joe Stringer, healthcare investment specialist, and partner at Octopus Ventures which invests in and supports start-up businesses across Europe, talks to HBI about his approach to investment ahead of his panel appearance at HBI 2022.

Two new rival hospitals open in central London

This week UK healthcare charity Nuffield Trust opened a hospital in its first central London site, located within the grounds of Barts Health NHS Trust’s St Bartholomew’s Hospital site, while Cleveland Clinic last week opened a large facility in Grosvenor Place, also in central London.

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.

Ardian “looking to sell Inovie stake”

Last week we reported that French lab group Inovie is currently in the process of looking for a new majority shareholder. Could private equity fund Ardian be looking to sell its (minority) stake.

Find Us